Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 20, Issue 10, Pages 1117-1120Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14712598.2020.1807001
Keywords
Infectious disease; Covid-19; SARS-CoV-2; host-directed
Ask authors/readers for more resources
Coronavirus disease 2019 (COVID-19) characterized by immuno-pathological host responses including pneumonia, lymphopenia, and cytokine storm that leads to severe lung inflammation, developed in acute respiratory distress syndrome (ARDS). In the absence of an effective vaccine or any definitive cure, the use of host-directed therapies is an effective alternative and demanding treatment option in the current pandemic outbreak of COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
